BE626857A - - Google Patents
Info
- Publication number
- BE626857A BE626857A BE626857DA BE626857A BE 626857 A BE626857 A BE 626857A BE 626857D A BE626857D A BE 626857DA BE 626857 A BE626857 A BE 626857A
- Authority
- BE
- Belgium
- Prior art keywords
- neomycin
- resin
- sep
- resins
- diarrhea
- Prior art date
Links
- 239000011347 resin Substances 0.000 description 41
- 229920005989 resin Polymers 0.000 description 41
- 229960004927 neomycin Drugs 0.000 description 38
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 21
- 206010012735 Diarrhoea Diseases 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 15
- 239000002156 adsorbate Substances 0.000 description 15
- 201000008286 diarrhea Diseases 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 150000002500 ions Chemical class 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- 239000011780 sodium chloride Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 201000010874 syndrome Diseases 0.000 description 8
- 241000282887 Suidae Species 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 235000013405 beer Nutrition 0.000 description 7
- 230000003115 biocidal Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 208000004232 Enteritis Diseases 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 235000011475 lollipops Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229940023488 Pill Drugs 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- -1 hydrogen ions Chemical class 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 2
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 2
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 2
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 206010061768 Chronic respiratory disease Diseases 0.000 description 2
- 208000003495 Coccidiosis Diseases 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 2
- 206010023076 Isosporiasis Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 2
- 231100000765 Toxin Toxicity 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 230000000741 diarrhetic Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 201000009910 diseases by infectious agent Diseases 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 230000000968 intestinal Effects 0.000 description 2
- 229940079866 intestinal antibiotics Drugs 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000006194 liquid suspension Substances 0.000 description 2
- 239000002609 media Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 2
- 244000045947 parasites Species 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 108020003112 toxins Proteins 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 1
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 1
- 244000144987 Brood Species 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 241000205706 Cystoisospora felis Species 0.000 description 1
- 240000006245 Dichrostachys cinerea Species 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 229940095399 Enema Drugs 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 210000003608 Feces Anatomy 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 241000152160 Ira Species 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- 210000004940 Nucleus Anatomy 0.000 description 1
- 208000008798 Osteoma Diseases 0.000 description 1
- 241000164466 Palaemon adspersus Species 0.000 description 1
- 210000002966 Serum Anatomy 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N Sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229960002180 Tetracycline Drugs 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 229940072172 Tetracycline antibiotics Drugs 0.000 description 1
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 1
- 210000001113 Umbilicus Anatomy 0.000 description 1
- 210000001635 Urinary Tract Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 101710006734 botF Proteins 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000031902 chemoattractant activity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000005712 crystallization Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000000378 dietary Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 230000001747 exhibiting Effects 0.000 description 1
- 235000020828 fasting Nutrition 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 1
- 230000002458 infectious Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000012499 inoculation medium Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003902 lesions Effects 0.000 description 1
- 235000014659 low sodium diet Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 101700006494 nucA Proteins 0.000 description 1
- 230000024241 parasitism Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229960001663 sulfanilamide Drugs 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 230000003612 virological Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE626857A true BE626857A (zh) |
Family
ID=197454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE626857D BE626857A (zh) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE626857A (zh) |
-
0
- BE BE626857D patent/BE626857A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1039192A (en) | Composition and method for treating scours | |
| CN1024497C (zh) | 一种制备西美娣定的稳定药物悬浮液的方法 | |
| CN1635881A (zh) | 甲福明的液体制剂 | |
| EP0412125B1 (en) | Pharmaceutical dosage form for the medication of fish | |
| TWI291351B (en) | Pharmaceutical composition for lowering blood-sugar | |
| US5204361A (en) | Method for treating laminitis in equine livestock | |
| JP4428553B2 (ja) | 家畜動物用予防及び／又は治療剤 | |
| CN108740305B (zh) | 围产期奶牛专用钙片及其制备方法 | |
| US3281322A (en) | Methods for controlling and treating renal calculi | |
| BE626857A (zh) | ||
| DK1776956T3 (en) | An agent for the prevention and / or treatment of calcium deficiency | |
| JPS6229520A (ja) | 哺乳動物の妊婦能力改良剤及びその製法 | |
| WO2001072145A1 (en) | Nutritional supplements formulated from bioactive materials | |
| SE423858B (sv) | Anvendning av salinomycin for att forbettra neringsupptagningen och tillvexten hos idisslare och kaniner | |
| US3085936A (en) | Gastro-enteritis-diarrheal syndrome treatment | |
| CN1262281C (zh) | 含有可可组分的药品、饮食品和饲料 | |
| US5436004A (en) | Administration of cholesterol reductase to humans | |
| JPS6051110A (ja) | 家畜のケト−ジス治療剤 | |
| JP5248438B2 (ja) | 反芻動物の乳生産改善剤 | |
| JPH0131487B2 (zh) | ||
| JPH07196525A (ja) | 胃炎、胃・十二指腸潰瘍の予防及び治療剤 | |
| RU2731271C2 (ru) | Способ профилактики жирового гепатоза печени у лактирующих коров | |
| JP5766121B2 (ja) | 口腔内への物質の送達のためのデリバリーシステム | |
| CN1714810A (zh) | 含有可可组分的药品、饮食品和饲料 | |
| SU578833A3 (ru) | Корм дл жвачных животных |